Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, Simpson RM, Unni AM, Lam WL, Lam S, Abraham N, Bennewith KL, Lockwood WW. Melese ES, et al. Among authors: shi r. Oncoimmunology. 2021 Dec 30;11(1):2010905. doi: 10.1080/2162402X.2021.2010905. eCollection 2022. Oncoimmunology. 2021. PMID: 35481284 Free PMC article.
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M, Cederberg RA, Hamilton MJ, LePard NE, Harbourne BT, Collier JL, Halvorsen EC, Shi R, Franks SE, Kim AY, Banáth JP, Hamer M, Rossi FM, Bennewith KL. Bosiljcic M, et al. Among authors: shi r. Breast Cancer Res. 2019 Sep 5;21(1):103. doi: 10.1186/s13058-019-1189-x. Breast Cancer Res. 2019. PMID: 31488209 Free PMC article.
Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.
Enfield KSS, Marshall EA, Anderson C, Ng KW, Rahmati S, Xu Z, Fuller M, Milne K, Lu D, Shi R, Rowbotham DA, Becker-Santos DD, Johnson FD, English JC, MacAulay CE, Lam S, Lockwood WW, Chari R, Karsan A, Jurisica I, Lam WL. Enfield KSS, et al. Among authors: shi r. Nat Commun. 2019 Nov 28;10(1):5438. doi: 10.1038/s41467-019-13295-y. Nat Commun. 2019. PMID: 31780666 Free PMC article.
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.
Johnson FD, Ferrarone J, Liu A, Brandstädter C, Munuganti R, Farnsworth DA, Lu D, Luu J, Sihota T, Jansen S, Nagelberg A, Shi R, Forcina GC, Zhang X, Cheng GSW, Spencer Miko SE, de Rappard-Yuswack G, Sorensen PH, Dixon SJ, Guha U, Becker K, Djaballah H, Somwar R, Varmus H, Morin GB, Lockwood WW. Johnson FD, et al. Among authors: shi r. Cell Rep. 2022 Feb 8;38(6):110343. doi: 10.1016/j.celrep.2022.110343. Cell Rep. 2022. PMID: 35139387 Free PMC article.
Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth.
Cederberg RA, Franks SE, Wadsworth BJ, So A, Decotret LR, Hall MG, Shi R, Hughes MR, McNagny KM, Bennewith KL. Cederberg RA, et al. Among authors: shi r. Front Oncol. 2022 Jun 8;12:841921. doi: 10.3389/fonc.2022.841921. eCollection 2022. Front Oncol. 2022. PMID: 35756626 Free PMC article.
Characterizing the secretome of EGFR mutant lung adenocarcinoma.
Luu JK, Johnson FD, Jajarmi J, Sihota T, Shi R, Lu D, Farnsworth D, Spencer SE, Negri GL, Morin GB, Lockwood WW. Luu JK, et al. Among authors: shi r. Front Oncol. 2024 Jan 8;13:1286821. doi: 10.3389/fonc.2023.1286821. eCollection 2023. Front Oncol. 2024. PMID: 38260835 Free PMC article.
4,490 results